PSA Screening for HIM Act

Plain-English Summary: PSA Screening for HIM Act

The PSA Screening for HIM Act is a Senate bill that appears to focus on expanding or improving access to PSA (Prostate-Specific Antigen) screening for men. PSA screening is a blood test used to help detect prostate cancer early, which is one of the most common cancers affecting men in the United States. The "HIM" in the title likely refers to men's health specifically. Because no official description has been provided, the full details of what the bill requires or changes are not entirely clear from the available information.

Based on its title and the committee it was referred to, the bill likely addresses insurance coverage, Medicare or Medicaid reimbursement, or other policies that affect whether men can access PSA testing without significant cost barriers. It may aim to remove out-of-pocket costs for the screening, set age guidelines for when men should be offered testing, or address disparities in who currently has access to prostate cancer screening.

The bill would most directly affect men — particularly those at higher risk for prostate cancer, such as older men and Black men, who statistically face higher rates of the disease. It could also affect insurance companies, healthcare providers, and government health programs depending on what specific requirements it establishes.

The bill was introduced in the Senate and referred to the Committee on Health, Education, Labor, and Pensions (HELP), where hearings have been held. It has not yet been voted on and would need to pass both chambers of Congress before becoming law.